abrdn Europe ex UK Income Equity Fund Institutional IncomeRegister to Unlock Ratings |
Performance History | 29/02/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 8.2 | 16.2 | -1.3 | 12.3 | 2.5 | |
+/-Cat | -1.2 | 0.8 | 7.5 | -1.2 | -0.4 | |
+/-B’mrk | 0.3 | -1.0 | 6.2 | -2.6 | -0.8 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
NAV 18/03/2024 | GBX 121.70 | |
Day Change | -0.57% | |
Morningstar Category™ | Europe ex-UK Equity | |
IA (formerly IMA) Sector | Europe Excluding UK | |
ISIN | GB00B3L7S958 | |
Fund Size (Mil) 18/03/2024 | GBP 370.35 | |
Share Class Size (Mil) 18/03/2024 | GBP 143.74 | |
Max Initial Charge | - | |
Ongoing Charge 21/12/2023 | 0.85% |
Investment Objective: abrdn Europe ex UK Income Equity Fund Institutional Income |
To generate income and some growth over the long term (5 years or more) by investing in European equities (company shares). The fund will invest at least 70% in equities and equity related securities of companies listed, incorporated, or domiciled in European countries, or companies that derive a significant proportion of their revenues or profits from European operations or have a significant proportion of their assets there. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Stuart Brown 01/01/2021 | ||
Inception Date 05/04/2009 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE World Eur Ex UK TR GBP | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for abrdn Europe ex UK Income Equity Fund Institutional Income | 29/02/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 5.48 |
SAP SE | Technology | 4.58 |
Novartis AG Registered Shares | Healthcare | 4.52 |
ASML Holding NV | Technology | 4.31 |
TotalEnergies SE | Energy | 3.86 |
Increase Decrease New since last portfolio | ||
abrdn Europe ex UK Income Equity Fund Institutional Income |